752 results match your criteria: "Rothmund-Thomson Syndrome"
Am J Med Genet A
September 2024
Department of Maternal-Fetal Biology, National Research Institute for Child Health and Development, Tokyo, Japan.
Pediatr Blood Cancer
December 2024
Division of Oncology and Center for Childhood Cancer Research, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.
Int J Mol Sci
August 2024
Genetica Medica, Dipartimento di Scienze Della Salute, Università Degli Studi di Milano, 20142 Milano, Italy.
Clin Cancer Res
November 2024
Division of Solid Tumor and Clinical Genetics, Department of Medicine and Pediatrics, Memorial Sloan Kettering Cancer Center, New York, New York.
Clin Case Rep
August 2024
Genetics Department Breast Cancer Research Center, Motamed Cancer Institute, ACECR Tehran Iran.
Arch Dermatol Res
May 2024
Tufts Medical Center, 800 Washington St, Boston, MA, 02111, USA.
DNA Repair (Amst)
February 2024
Institute of Cancer and Genomic Sciences, College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK. Electronic address:
Mol Genet Genomic Med
January 2024
Obstetrics Department, Shenzhen Maternity and Child Healthcare Hospital, Shenzhen, Guangdong Province, China.
Front Aging
November 2023
Genomic Stability Unit, Department of Biochemistry, Institute of Chemistry, University of São Paulo, São Paulo, Brazil.
J Biol Chem
September 2023
Signal Transduction Laboratory, National Institute of Immunology, New Delhi, India; National Institute of Biomedical Genomics, Kalyani, India. Electronic address:
Blood Sci
April 2023
National Research Center for Translational Medicine, State Key Laboratory of Medical Genomics, Shanghai Institute of Hematology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China.
J Med Genet
November 2023
Departamento de Genética e Biologia Evolutiva do Instituto de Biociências, Universidade de São Paulo, Sao Paulo, Brazil
Genet Med
July 2023
Department of General Pediatrics, Neonatology and Pediatric Cardiology, Medical Faculty, University Hospital Düsseldorf, Heinrich-Heine-University, Düsseldorf, Germany. Electronic address:
Nat Commun
March 2023
Department of Cancer Genetics and Epigenetics, Beckman Research Institute, City of Hope, Duarte, CA, 91010-3000, USA.
Int J Mol Sci
February 2023
Experimental Research Laboratory of Medical Cytogenetics and Molecular Genetics, IRCCS Istituto Auxologico Italiano, Via Ariosto 13, 20145 Milan, Italy.
JAAD Case Rep
January 2023
Department of Dermatology, Yale School of Medicine, New Haven, Connecticut.
Am J Med Genet A
January 2023
Pediatric Endocrinology Unit, Department of Pediatrics, Hospital de Santa Maria - Centro Hospitalar Universitário Lisboa Norte, EPE, Lisbon, Portugal.
Fam Cancer
January 2023
Medical Oncology Department, Vall d'Hebron Barcelona Hospital Campus, Passeig Vall dHebron 119-129, 08035, Barcelona, Spain.
Pediatr Int
January 2022
Department of Endocrinology, Hematology, and Gerontology, Chiba University Graduate School of Medicine, Chiba, Japan.
Background: Rothmund-Thomson syndrome (RTS) is an autosomal recessive genetic disorder characterized by poikiloderma of the face, small stature, sparse scalp hair, juvenile cataract, radial aplasia, and predisposition to cancers. Due to the rarity of RTS, the situation of patients with RTS in Japan has not been elucidated.
Methods: In 2010 and 2020, following the results of a primary questionnaire survey, a secondary questionnaire survey on RTS was conducted nationwide to investigate the number of RTS cases and their associated skin lesions, bone lesions, other clinical features, and quality of life in Japan.
Cell Death Dis
April 2022
Department of Genetics, ELTE Eötvös Loránd University, Budapest, Hungary.
Cancer Genet
April 2022
Texas Children's Cancer and Hematology Centers, Department of Pediatrics, Baylor College of Medicine, Houston, TX, 77030 United States. Electronic address:
Bol Med Hosp Infant Mex
May 2022
Departamento de Dermatopatología, Hospital General Dr. Manuel Gea González. Mexico City, Mexico.
PLoS Genet
December 2021
Department of Integrative Biology and Pharmacology, McGovern Medical School, The University of Texas Health Science Center at Houston, Houston, Texas, United States of America.
Rothmund-Thomson syndrome (RTS) is an autosomal recessive genetic disorder characterized by poikiloderma, small stature, skeletal anomalies, sparse brows/lashes, cataracts, and predisposition to cancer. Type 2 RTS patients with biallelic RECQL4 pathogenic variants have multiple skeletal anomalies and a significantly increased incidence of osteosarcoma. Here, we generated RTS patient-derived induced pluripotent stem cells (iPSCs) to dissect the pathological signaling leading to RTS patient-associated osteosarcoma.
View Article and Find Full Text PDF